Alexion wins early U.S. approval for rare blood disorder drug
The U.S. Food and Drug Administration approved on Friday Alexion Pharmaceuticals Inc's rare blood disorder drug Ultomiris, an early backing that also solidifies the company's dominant market position.
from Reuters: Health https://reut.rs/2Gx1hgw
from Reuters: Health https://reut.rs/2Gx1hgw
No comments